Please login to the form below

Not currently logged in
Email:
Password:

olipudase alfa

This page shows the latest olipudase alfa news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s rare disease drug olipudase alfa scores in late-stage study

Sanofi’s rare disease drug olipudase alfa scores in late-stage study

Olipudase alfa is designed to replace the enzyme that is deficient in the inherited disease, also known as Neimann-Pick disease. ... Both of these findings are consistent across the clinical studies with olipudase alfa.

Latest news

  • Sanofi rare disease drug a breakthrough, says FDA Sanofi rare disease drug a breakthrough, says FDA

    The FDA gave the coveted status to olipudase alfa, which is designed to replace the enzyme that is deficient in the inherited disease, also known as acid sphingomyelinase deficiency (ASMD). ... Genzyme is developing olipudase alfa (GZ402665) for the type

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics